UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 14, 2022 4:30 P.M.
Form:
S-1
CIK:
0001614067
Company Name:
Aridis Pharmaceuticals, Inc.
File Number:
333-268701